Wynne Weston-Davies

Nessuna posizione attualmente

Health Technology

Profilo

Wynne Weston-Davies worked as a Medical Director at Evolutec Group Plc, Volution Immuno Pharmaceuticals SA, and Akari Therapeutics Plc.
He also worked as a Medical Director at Varleigh Immuno Pharmaceuticals Uk Ltd.
from 2009 to 2014.

Precedenti posizioni note di Wynne Weston-Davies

Società	Posizione	Fine
Varleigh Immuno Pharmaceuticals Uk Ltd.	Direttore Tecnico/Scientifico/R&S	01/01/2014
Evolutec Group Plc Evolutec Group Plc BiotechnologyHealth Technology Evolutec Group Plc is an biopharmaceutical company, which discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. It was founded in1998 and headquartered in Oxford, United Kingdom.	Direttore Tecnico/Scientifico/R&S	-
Volution Immuno Pharmaceuticals SA Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Part of Akari Therapeutics Plc, Volution Immuno Pharmaceuticals SA is a Swiss company that develops anti-complement and anti-inflammatory molecules to treat orphan conditions in the autoimmune and inflammatory diseases sectors. The company is based in Geneva, Switzerland. The company was founded by Raymond Prudo-Chlebosz, who has been the CEO since incorporation. Volution Immuno Pharmaceuticals was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million.	Direttore Tecnico/Scientifico/R&S	-
AKARI THERAPEUTICS, PLC	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Wynne Weston-Davies

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private